Cvm stock forecast 2025 quant models for CVM stock forecast

Quant models for CVM stock forecast 2025 run on multi-year data suggest high sensitivity to clinical milestone announcements. In best-case runs, statistical probability indicates a price hitting $11.20 before end of year. OK. Good morning. Thank you for the opportunity. So my first question is on your recent decision to launch a strategic review for Thompson, which you mentioned could include a potential sale of the asset. Pre-surgical tumor regressions confirmed at surgery forecast survival benefit. CVM stock forecast 2025 gains from broader biotech market inflows as ETF allocations shift toward emerging oncology players. Sector liquidity impacts can accelerate price movements beyond analyst conservatism.